Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1692-1698

  Hamilton, Stephanie M ^a,b   Bayer, Clifford R ^a   Stevens, Dennis L ^a,c   Lieber, Richard L ^d   Bryant, Amy E ^a,b,c,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IDAHO   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOLOGY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ECCENTRIC MUSCLE CONTRACTION; FEMALE; GENE EXPRESSION; IN VIVO STUDY; MOUSE; MUSCLE INJURY; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TISSUE HOMOGENATE; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GENE EXPRESSION REGULATION; MICE; MUSCLE, SKELETAL; MUSCULAR DISEASES; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIMENTIN;

EID: 56649088259     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593016     Document Type: Article

References (28)

1. Bisno AL, Stevens DL. Streptococcal infections in skin and soft tissues. N Engl J Med 1996; 334:240-5.
2. Stevens DL, Tanner MH, Winship J, et al. Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with a toxic shock-like syndrome. N Engl J Med 1989; 321:1-7.
3. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR. Streptococcal myositis. Arch Intern Med 1985; 145:1020-3.
4. Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol 2007; 17:878-81.
5. Schurr M, Engelhardt S, Helgerson R. Limb salvage for streptococcal gangrene of the extremity. Am J Surg 1998; 175:213-7.
6. Stevens DL. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21:977-80.
7. Aronoff DM, Bloch KC. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 2003; 82:225-35.
8. Bryant AE, Bayer CR, Huntington JD, Stevens DL. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 2006; 193:1685-92.
9. Barash IA, Mathew L, Ryan AF, Chen J, Lieber RL. Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 2004; 286:C355-64.
10. Peters D, Barash IA, Burdi M, et al. Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J Physiol 2003; 553:947-57.
11. Vater R, Cullen MJ, Harris JB. The expression of vimentin in satellite cells of regenerating skeletal muscle in vivo. Histochem J 1994; 26:916-28.
12. Vaittinen S, Lukka R, Sahlgren C, et al. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol 2001; 60:588-97.
13. Vaittinen S, Lukka R, Sahlgren C, et al. Specific and innervation-regulated expression of the intermediate filament protein nestin at neuromuscular and myotendinous junctions in skeletal muscle. Am J Pathol 1999; 154:591-600.
14. Bornemann A, Schmalbruch H. Desmin and vimentin in regenerating muscles. Muscle Nerve 1992; 15:14-20.
15. Hentzen ER, Lahey M, Peters D, et al. Stress-dependent and -independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats. J Physiol 2006; 570:157-67.
16. Taylor FB Jr, Bryant AE, Blick KE, et al. Staging of the baboon response to group A streptococcus administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response. Clin Infect Dis 1999; 29:167-77.
17. Barnham MR, Weightman NC, Anderson AW, Tanna A. Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK. Clin Microbiol Infect 2002; 8:174-81.
18. Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103:783-90.
19. Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107:1108-15.
20. Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008; 14:202-9.
21. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005; 288:R345-53.
22. Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204:1057-69.
23. Lluis F, Roma J, Suelves M, et al. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 2001; 97:1703-11.
24. Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004; 287:C475-83.
25. Courtney HS, Hasty DL, Dale JB. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med 2002; 34:77-87.
26. Natanson S, Sela S, Moses A, Musser J, Caparon M, Hanski E. Distribution of fibronectin-binding proteins among group A streptococci of different M types. J Infect Dis 1995; 171:871-8.
27. Mackey AL, Donnelly AE, Turpeenniemi-Hujanen T, Roper HP. Skeletal muscle collagen content in humans after high-force eccentric contractions. J Appl Physiol 2004; 97:197-203.
28. Lovering RM, De Deyne PG. Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury. Am J Physiol Cell Physiol 2004; 286:C230-8.